Course

Advances in treatments of hereditary neuromuscular diseases in children and adults

Tuesday, June 6, 2023

8:00 AM – 10:30 AM MST

Location:CC: Theatre - 1st Flr

Audience:

Adult Neurologist, Child Neurologist, Neurophysiologist, Resident, Fellow, Nurses with interest in topic

Learning Level:

Basic (Resident, New Information), Intermediate (Practicing Physician), Advanced (Special Interest, Higher Level Discussion)

Learning Format:

Case studies, Lecture/plenary method, Question and answer sessions

CanMEDs Roles:

Medical Expert, Scholar, Leader, Health Advocate, Professional

Co-Chair(s)

MM

Michelle Mezei
HM

Hugh McMillan

Speaker(s)

Jodi Warman-Chardon, MD, MSc, FRCPC (Neurology)
CN

Cam-Tu Nguyen
CC

Craig Campbell
GP

Gerald Pfeffer
HL

Hanns Lochmuller

This course will review new and emerging treatments and therapeutic options for the of hereditary neuromuscular diseases in both children and adults. An overview of the changing landscape in treatment of neuromuscular disease will be given with a focus on therapies for: spinal muscular atrophy (Dr. Cam-Tu Nguyen); muscular dystrophies (Dr. Craig Campbell); myopathies (Dr. Gerald Pfeffer) and myasthenic syndromes (Dr. Hanns Lochmuller)

Learning Objectives:

Understand all available treatment options for children and adults with neuromusuclar disease
Understand potential adverse events of treatments to optimize choice of therapy and monitoring
Recognize the utility of magnetic resonance imaging and other diagnostic tests evaluating a patient with a neuromuscular disorder

Presentations:

8:00 AM – 8:30 AM MST

Overview of changing landscape in treatment of neuromuscular disease
Speaker: Jodi Warman-Chardon, MD, MSc, FRCPC (Neurology)
8:30 AM – 9:00 AM MST

Spinal muscular atrophy
Speaker: Cam-Tu Nguyen
9:00 AM – 9:30 AM MST

Muscular dystrophies
Speaker: Craig Campbell
9:30 AM – 10:00 AM MST

Myopathies
Speaker: Gerald Pfeffer
10:00 AM – 10:30 AM MST

Congenital myasthenic syndromes
Speaker: Hanns Lochmuller